Clinical Trial Update: A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma [NA]

View source ↗

Summary

A multicenter prospective trial of the OMNI Surgical System in pseudophakic eyes with open-angle glaucoma was terminated; results were posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Open-angle Glaucoma

Drugs mentioned

• OMNI Surgical System

Snippet

Sponsor: Sight Sciences, Inc. | Conditions: Glaucoma, Open-Angle | NA | Status: TERMINATED | Results posted: 2022-06-07